Category:Hedgehog pathway inhibitors
Revision as of 18:06, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Chemotherapy" to "Category:Chemotherapeutic")
A class of drugs that target one or more components of the Hedgehog signaling pathway. Vismodegib is the first in class to be FDA approved.
Pages in category "Hedgehog pathway inhibitors"
The following 3 pages are in this category, out of 3 total.